EN
CN
Home · About Singularity

Introduction

Organ MedicineInnovative biopharmaceutical technology enterprises engaged in research and industrial development

Singularity Medical is a national high-tech enterprise engaged in organ medicine and industrial development. Its core business covers organ transplantation, drug screening, human organ disease models, animal live organ teaching, etc. It has core technologies such as ischemia free transplantation and in vitro organ maintenance. It is a specialized and innovative enterprise in Guangdong Province and a leading enterprise in the high-end medical device chain in Guangzhou. In 2023, it was awarded the key special support of the national key research and development plan "Disruptive Technology Innovation". The company has research and development centers in Yuexiu District of Guangzhou and Guangming District of Shenzhen, and a GMP production base in Zengcheng District of Guangzhou.

Qualification and Honors

Team of Scientists

Huang JiefuHonorary Advisor

Former Deputy Minister of Health Former Deputy Director of the Central Health Commission (Ministerial level)

Former Deputy Minister of Health

Former Deputy Director of the Central Health Commission (Ministerial level)

He XiaoshunProfessor

Discipline Leader and Director of Zhongshan First Hospital Organ Transplantation Center Visiting Professor at Harvard University and Cornell University President of the World Society fo...

Discipline Leader and Director of Zhongshan First Hospital Organ Transplantation Center

Visiting Professor at Harvard University and Cornell University

President of the World Society for Organ Transplantation in China

Director of Guangdong Provincial Key Laboratory of Organ Donation and Transplantation Immunology

Director of the Institute of Organ Donation and Transplantation Immunology at Sun Yat sen University

Member of the Chinese Organ Donation and Transplantation Committee

Chairman of the Precision Medicine Branch of the Chinese Hospital Association

Standing Committee Member of the Organ Transplantation Branch of the Chinese Medical Association

President of Guangdong Society of Organ Medicine and Technology

Chairman of the Organ Transplantation Branch of Guangdong Medical Association


Academic contributions:

1. Invented ischemia free organ transplantation technology, solving the global problem of organ ischemia injury;

2. Establishing a simplified multi organ transplantation technology system, providing a cure for end-stage multi organ diseases;

3. Overcome the technical difficulties of organ donation for cardiac death and provide technical support for the reform of organ donation for Chinese citizens;

4. Propose the concept of "organ medicine" and open up a new field of medical research and treatment at the organ level.


Dean He has published 595 papers, with 171 SCI papers published as the first/corresponding author. He has edited 12 monographs, including "Non ischemic Organ Transplantation," and has obtained 6 international patents and 18 Chinese patents, achieving achievement transformation. His research results have been included in 11 international clinical guidelines and consensus. Guided students to win 21 international academic awards, was selected as one of the "Top 10 Scientific and Technological Innovations in China" by eight ministries including the Chinese Academy of Engineering in 2017, was appointed as a visiting professor named "Joseph Murray" by Harvard University (the only one in Asia), won the only special prize in the 2020 International Quality Innovation Competition (the first in China, ranking first), won the first prize in Guangdong Province's Science and Technology Progress Award (2021, ranking first), won 2 national science and technology progress second prizes, 6 provincial and ministerial level science and technology progress first prizes, and holds 24 international and domestic patents.